PI3K in CLL: are 2 isoforms better than 1?

Blood. 2014 Dec 4;124(24):3508-10. doi: 10.1182/blood-2014-10-605089.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Class I Phosphatidylinositol 3-Kinases / antagonists & inhibitors*
  • Enzyme Inhibitors / pharmacology*
  • Female
  • Humans
  • Isoquinolines / pharmacology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male
  • Neoplasm Proteins / antagonists & inhibitors*
  • Purines / pharmacology*
  • Signal Transduction / drug effects*

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Isoquinolines
  • Neoplasm Proteins
  • Purines
  • duvelisib
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CD protein, human